(Q33340528)

English

Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Candida glabrata

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Candida krusei

1 reference

based on heuristic

inferred from title

2

object named as

van Rhee F

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

author name string

Safdar A

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Henslee-Downey JP

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Singhal S

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Mehta J

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

language of work or name

0 references

publication date

1 November 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

873-878

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703252

21 January 2018

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703252

21 January 2018

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703252

21 January 2018

Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703252

21 January 2018

Retrospective analysis of yeast colonization and infections in paediatric bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703252

21 January 2018

Candida krusei fungemia. An escalating serious infection in immunocompromised patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703252

21 January 2018

Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703252

21 January 2018

Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703252

21 January 2018

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703252

21 January 2018

Importance of Candida species other than C. albicans as pathogens in oncology patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703252

21 January 2018

Emerging fungal pathogens, drug resistance and the role of lipid formulations of amphotericin B in the treatment of fungal infections in cancer patients: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703252

21 January 2018

Prospective study of Candida species in patients at a comprehensive cancer center

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703252

21 January 2018

Antifungal resistance trends towards the year 2000. Implications for therapy and new approaches

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703252

21 January 2018

Fungemia caused by "nonpathogenic" yeasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703252

7 January 2021

based on heuristic

inferred from DOI database lookup

Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703252

7 January 2021

based on heuristic

inferred from DOI database lookup

Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703252

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703252

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients. Bone Marrow Transplantation Team

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703252

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of Fluconazole Resistance inCandida albicansCausing Disseminated Infection in a Patient Undergoing Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703252

7 January 2021

based on heuristic

inferred from DOI database lookup

The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703252

7 January 2021

based on heuristic

inferred from DOI database lookup

The epidemiology of hematogenous candidiasis caused by different Candida species

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703252

7 January 2021

based on heuristic

inferred from DOI database lookup

Nosocomial candidemia: risk factors and attributable mortality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703252

7 January 2021

based on heuristic

inferred from DOI database lookup

Breakthrough Candida tropicalis fungemia during ketoconazole prophylaxis in cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703252

7 January 2021

based on heuristic

inferred from DOI database lookup

Rising Incidence of Candida parapsilosis Fungemia in Patients with Hematologic Malignancies: Clinical Aspects, Predisposing Factors, and Differential Pathogenicity of the Causative Strains

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703252

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1703252

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33340528&oldid=2195261188"